Prestige Consumer [PBH] vs Alkermes plc [ALKS] Detailed Stock Comparison

Prestige Consumer Healthcare Inc.

NYSE
Loading...

Alkermes plc

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Prestige Consumer Healthcare Inc. wins in 11 metrics, Alkermes plc wins in 9 metrics, with 0 ties. Prestige Consumer Healthcare Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Prestige Consumer Healthcare Inc. Alkermes plc Better
P/E Ratio (TTM) 15.18 23.71 Prestige Consumer Healthcare Inc.
Price-to-Book Ratio 1.49 3.09 Prestige Consumer Healthcare Inc.
Debt-to-Equity Ratio 59.00 3.85 Alkermes plc
PEG Ratio -0.75 -0.36 Alkermes plc
EV/EBITDA 10.24 18.26 Prestige Consumer Healthcare Inc.
Profit Margin (TTM) 16.90% 16.37% Prestige Consumer Healthcare Inc.
Operating Margin (TTM) 29.10% 15.11% Prestige Consumer Healthcare Inc.
EBITDA Margin (TTM) 29.10% 15.11% Prestige Consumer Healthcare Inc.
Return on Equity 10.31% 14.72% Alkermes plc
Return on Assets (TTM) 6.13% 6.99% Alkermes plc
Free Cash Flow (TTM) $243.29M $480.33M Alkermes plc
1-Year Return -44.52% 37.83% Alkermes plc
Price-to-Sales Ratio (TTM) 2.51 3.83 Prestige Consumer Healthcare Inc.
Enterprise Value $3.74B $5.13B Alkermes plc
EV/Revenue Ratio 3.39 3.48 Prestige Consumer Healthcare Inc.
Gross Profit Margin (TTM) 55.52% 87.98% Alkermes plc
Revenue per Share (TTM) $23 $9 Prestige Consumer Healthcare Inc.
Earnings per Share (Diluted) $3.79 $1.43 Prestige Consumer Healthcare Inc.
Beta (Stock Volatility) 0.47 0.39 Alkermes plc
Short % of Float 8.04% 15.90% Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. vs Alkermes plc Stock Performance Analysis

Loading Price Chart...

PBH
ALKS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Prestige Consumer Healthcare Inc.-0.85%-4.56%-17.14%-33.12%-23.22%-25.14%
Alkermes plc3.46%10.63%20.92%36.60%42.63%46.21%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Prestige Consumer Healthcare Inc.-44.52%-18.75%-4.94%-11.39%281.46%345.87%
Alkermes plc37.83%42.97%82.80%-6.37%138.77%104.61%

Performance & Financial Health Analysis: Prestige Consumer Healthcare Inc. vs Alkermes plc

MetricPBHALKS
Market Information
Market Cap i$2.78B$5.55B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i403,6771,637,141
90 Day Avg. Volume i517,8762,593,004
Last Close$45.44$42.75
52 Week Range$42.62 - $87.12$25.17 - $42.87
% from 52W High-47.84%-0.28%
All-Time High$90.04 (Mar 10, 2025)$98.50 (Feb 28, 2000)
% from All-Time High-49.53%-56.60%
Growth Metrics
Quarterly Revenue Growth-0.02%-0.11%
Quarterly Earnings Growth-0.24%-0.66%
Financial Health
Profit Margin (TTM) i0.17%0.16%
Operating Margin (TTM) i0.29%0.15%
Return on Equity (TTM) i0.10%0.15%
Debt to Equity (MRQ) i59.003.85
Cash & Liquidity
Book Value per Share (MRQ)$38.66$10.99
Cash per Share (MRQ)$1.32$3.53
Operating Cash Flow (TTM) i$276.63M$520.75M
Levered Free Cash Flow (TTM) i$207.17M$-363,090,624
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Prestige Consumer Healthcare Inc. vs Alkermes plc

MetricPBH (Apr 24, 2026)ALKS (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i15.1823.71
Forward P/E i11.9648.44
PEG Ratio i-0.75-0.36
Price to Sales (TTM) i2.513.83
Price to Book (MRQ) i1.493.09
Market Capitalization
Market Capitalization i$2.78B$5.55B
Enterprise Value i$3.74B$5.13B
Enterprise Value Metrics
Enterprise to Revenue i3.393.48
Enterprise to EBITDA i10.2418.26
Risk & Other Metrics
Beta i0.470.39
Book Value per Share (MRQ) i$38.66$10.99

Financial Statements Comparison: Prestige Consumer Healthcare Inc. vs Alkermes plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPBH (2025)ALKS (2025)
Revenue/Sales i1.14B1.48B
Cost of Goods Sold i503.30M196.46M
COGS % of Revenue i44.2%13.3%
Gross Profit i634.46M1.28B
Gross Margin i55.8%86.7%
Research & Development iN/A323.96M
Operating Income (EBIT) i349.24M253.96M
Operating Margin i30.7%17.2%
EBITDA i374.46M330.89M
EBITDA Margin i32.9%22.4%
Pre-Tax Income i284.19M291.45M
Pre-Tax Income % of Revenue i25.0%19.7%
Income Tax i69.58M49.79M
Income Tax % of Revenue i6.1%3.4%
Net Income (Profit) i214.61M241.66M
Profit Margin i18.9%16.4%

Balance Sheet & Liquidity Metrics

MetricPBH (2025)ALKS (2025)
Cash & Equivalents i97.88M388.57M
Total Current Assets i448.33M1.93B
Total Current Assets % of Revenue i39.4%130.7%
Total Current Liabilities i106.62M543.44M
Total Current Liabilities % of Revenue i9.4%36.8%
Long-Term Debt i1.04B63.25M
Long-Term Debt % of Revenue i91.0%4.3%
Total Shareholders Equity i1.83B1.82B
Retained Earnings i1.56B-734.79M
Retained Earnings % of Revenue i136.7%-49.8%
Property, Plant & Equipment i53.29M77.21M

Cash Flow Statement Comparison

MetricPBH (2025)ALKS (2025)
Operating Cash Flow i227.18M545.23M
Operating Cash Flow % of Revenue i20.0%36.9%
Capital Expenditures i-8.22M-39.33M
Free Cash Flow i243.29M480.33M
FCF Margin i21.4%32.5%
Debt Repayment i-139.54M0
Common Stock Repurchase i-51.51M0

Short Interest & Institutional Ownership Analysis

MetricPBHALKS
Shares Short i2.69M19.01M
Short Ratio i5.787.03
Short % of Float i8.04%15.90%
Shares Outstanding i47.32M165.61M
Float Shares i46.75M154.04M
% Held by Insiders i1.30%1.42%
% Held by Institutions i111.41%110.87%
% Held by Public i-12.71%-12.29%

Dividend Analysis & Yield Comparison: Prestige Consumer Healthcare Inc. vs Alkermes plc

MetricPBHALKS
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A